RC-3095

Names

[ Name ]:
RC-3095

[Synonym ]:
L-Histidinamide, N-[[(3R)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-3-yl]carbonyl]-L-glutaminyl-L-tryptophylalanyl-L-valylglycyl-N-[1-[[[(1S)-1-(aminocarbonyl)-3-methylbutyl]amino]methyl]-3-methylbu tyl]-
N-[(3R)-2,3,4,9-Tetrahydro-1H-β-carbolin-3-ylcarbonyl]-L-glutaminyl-L-tryptophylalanyl-L-valylglycyl-N-(1-{[(2S)-1-amino-4-methyl-1-oxo-2-pentanyl]amino}-4-methyl-2-pentanyl)-L-histidinamide

Biological Activity

[Description]:

RC-3095 is a bombesin/gastrin releasing peptide receptor antagonist[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> GPCR/G Protein >> Bombesin Receptor

[References]

[1]. Konturek SJ, et al. Antagonism of receptors for bombesin, gastrin and cholecystokinin in pancreatic secretion and growth. Digestion. 1991;48(2):89-97.

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
1547.9±65.0 °C at 760 mmHg

[ Molecular Formula ]:
C₅₆H₇₉N₁₅O₉

[ Molecular Weight ]:
1106.322

[ Flash Point ]:
889.9±34.3 °C

[ Exact Mass ]:
1105.618530

[ LogP ]:
1.05

[ Vapour Pressure ]:
0.0±0.3 mmHg at 25°C

[ Index of Refraction ]:
1.610

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Articles

The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats.

J. Pharmacol. Exp. Ther. 337(3) , 822-9, (2011)

Bombesin is a pruritogenic agent that causes intense itch-scratching activity in rodents. Bombesin has high affinity for the gastrin-releasing peptide (GRP) receptor (GRPr) and the neuromedin B (NMB) ...

Facilitation of the inhibitory transmission by gastrin-releasing peptide in the anterior cingulate cortex.

Mol. Pain 6 , 52, (2010)

Gastrin-releasing peptide (GRP) has been proposed as a peptidergic molecule for behavioral fear and itching. Immunohistochemistry and in situ hybridization studies have shown that GRP and GRP receptor...

New agonist- and antagonist-based treatment approaches for advanced prostate cancer.

J. Int. Med. Res. 40(4) , 1217-26, (2012)

Increased understanding of prostate cancer biology has led to new treatment strategies and promising new agents for treating prostate cancer, in particular peptide-based agonists and antagonists. In t...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.